SCHEMBL30932147

SCHEMBL30932147

CC[C@H](C)[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAGI3 Q5TCQ9 1/20 0.56
▸ CASP1 P29466 1/20 0.54
▸ CASP3 P42574 1/20 0.54
▸ CASP4 P49662 1/20 0.54
▸ CASP5 P51878 1/20 0.54
▸ CASP7 P55210 1/20 0.54
▸ CASP9 P55211 1/20 0.54
▸ CASP6 P55212 1/20 0.54
▸ CASP8 Q14790 1/20 0.54
▸ CASP10 Q92851 1/20 0.54
▸ CCKBR P32239 9/20 0.53
▸ CCKAR P32238 3/20 0.53
▸ OPRD1 P41143 1/20 0.53
▸ EDNRA P25101 1/20 0.52
▸ ERBB2 P04626 1/20 0.52
▸ IL23R Q5VWK5 3/20 0.51
▸ PCSK9 Q8NBP7 1/20 0.49
▸ CXCR4 P61073 1/20 0.49
▸ GLP1R P43220 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29386744 0.86 MAGI3 (0.55) MAGI3CASP1CASP3CASP4CASP5
SCHEMBL29914602 0.86 MAGI3 (0.60) MAGI3CASP1CASP3CASP4CASP5
SCHEMBL30932143 0.85 GLP1R (0.60) CXCR4GLP1R
SCHEMBL29876331 0.85 MAGI3 (0.54) MAGI3CASP1CASP3CASP4CASP5
SCHEMBL30512696 0.84 GLP1R (0.58) CCKBRCCKAROPRD1CXCR4GLP1R
SCHEMBL30932144 0.84 GLP1R (0.59) GLP1R
SCHEMBL31299590 0.83 IL23R (0.58) CCKBRCCKAROPRD1ERBB2IL23R
SCHEMBL31668917 0.82 CCKBR (0.60) CCKBRCCKARIL23R
SCHEMBL30595758 0.82 IL23R (0.57) IL23RCXCR4GLP1R
SCHEMBL7400882 0.82 EDNRA (0.71) MAGI3CASP1CASP3CASP4CASP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622992-A1 COMPSTATIN ANALOGS FOR VECTOR-BASED THERAPY Amyndas Pharmaceuticals US LLC (US) 2025-10-01 — — EP disclosed
WO-2024110878-A1 COMPSTATIN ANALOGS FOR VECTOR-BASED THERAPY AMYNDAS PHARMACEUTICALS US LLC (US) 2024-05-30 — — WO disclosed
Send feedback